Pharmaceutical Contract Development and Manufacturing Market
Pharmaceutical Contract Development and Manufacturing Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Pharmaceutical Contract Development and Manufacturing Market Size and Growth
The Pharmaceutical Contract Development and Manufacturing market is projected to grow significantly, driven by increasing outsourcing needs and rising R&D costs. The market size is estimated to reach approximately $100 billion by 2026, reflecting robust demand for specialized manufacturing and development services, alongside advancements in biopharmaceutical technologies and regulatory complexities.
Companies Covered
(Covid 19 Impact Covered)
◍ Thermo Fisher Scientific Inc.
◍ Catalent, Inc.
◍ Lonza Group Ltd
◍ Recipharm AB
◍ Vetter Pharma International GMBH
◍ FAMAR Health Care Services
◍ AbbVie Inc.
◍ Aenova Group
◍ Consort Medical plc
◍ Almac Group
◍ Siegfried Holding AG
The Pharmaceutical Contract Development and Manufacturing Market features key players like Thermo Fisher, Catalent, and Lonza, supplying comprehensive solutions. These firms enhance market growth through innovative services, streamlined processes, and diverse capabilities. Notable sales revenues include:
- Thermo Fisher: $39.2 billion
- Catalent: $3.7 billion
- Lonza: $5.3 billion
◍ Boehringer Ingelheim International GmbH
◍ Evonik Industries AG
Market Segmentation
By Application
Big Pharma
Small Pharma
Generic Pharma
CRO
By
Product
◍ Pharmaceutical Manufacturing Services
Biologics Manufacturing Services
Drug Development Services
Request Sample Report
$ 32.30 Billion
Request Sample Report
